initiate coverage

Broker's Calls

Boustead Singapore started at 'buy' on 'reliable prospects': UOB Kay Hian

UOB Kay Hian is initiating coverage on infrastructure-related engineering and technology group Boustead Singapore.

Broker's Calls

DBS initiates coverage on Fu Yu Corp with 35 cents price target

DBS Group Research is initiating coverage on Fu Yu with a target price of 35 cents, representing a 40% upside for the stock.

Broker's Calls

Centurion Corp started at 'add' by CGS-CIMB on strong growth potential

The group is expected to achieve PATMI growth of 7.7-13.8% for FY20-21 due to a 15.2% growth in capacity.

Broker's Calls

Koufu primed for accelerated growth: SAC Capital

SINGAPORE (Dec 11): SAC Capital is initiating a “buy” recommendation on food court and coffeeshop manager Koufu with a target price of 87 cents.
Lendlease Global REIT started at ‘buy’ by DBS on income visibility, acquisition pipeline

Broker's Calls

Lendlease Global REIT started at 'buy' by DBS on strong income visibility, acquisition pipeline

SINGAPORE (Dec 6): With only two assets under its belt, LendLease Global Commercial REIT (LLGCR) might not appear to be an attractive prospect for investors. But some analysts are keeping a close eye on the recently listed retail REIT.

Investing ideas

AEM started at 'buy' by DBS as demand for new technology picks up

SINGAPORE (Nov 29): Precision engineering services firm AEM Holdings is flying high. Year-to-date, its share price has more than doubled to close at $1.71 on Nov 28, climbing from 82.5 cents at the start of the year.

Broker's Calls

EC World REIT started at 'outperform' amid China e-commerce boom: KGI

SINGAPORE (Nov 25): KGI Securities is initiating coverage on EC World REIT (ECW) with an “outperform” recommendation and a target price of 84 cents – representing a total upside of more than 23%, including a divided yield forecast of 9.1% for FY20.

Broker's Calls

SAC Capital starts Hyphens Pharma on 'buy' as healthcare spending expected to rise

SINGAPORE (Nov 8): SAC Capital has initiated coverage on Hyphens Pharma International, a specialty pharmaceutical and consumer healthcare group, with a “buy” rating and target price of 28.5 cents.

Broker's Calls

New REIT on the block Lendlease Global REIT started at 'outperform' as top S-REIT pick: Daiwa

SINGAPORE (Oct 15): Daiwa Capital Markets is initiating coverage on Lendlease Global Commercial REIT with an “outperform” rating and a target price of $1.01.

Broker's Calls

CGS-CIMB starts Boustead on 'add' as it fires on all cylinders

SINGAPORE (Sept 23): CGS-CIMB Research is initiating coverage on Boustead Singapore with an “add” recommendation and a target price of $1.00 – representing an upside of more than 36%.
×